A phase I/IIa clinical trial of third-generation autologous chondrocyte implantation (IK-01) for focal cartilage injury of the knee

A phase I/IIa clinical trial of third-generation autologous chondrocyte implantation (IK-01) for focal cartilage injury of the knee

Background/objective: The purpose of this study was to report the outcomes of a clinical trial conducted in Japan to assess the safety and effectiveness of third-generation autologous chondrocyte implantation (ACI) using IK-01 (CaReS™), which does not require flap coverage, in the treatment of patie...

Full description

Bibliographic Details
Main Authors: Takehiko Matsushita, Tomoyuki Matsumoto, Daisuke Araki, Kanto Nagai, Yuichi Hoshino, Takahiro Niikura, Atsuhiko Kawamoto, Masahiro J. Go, Shin Kawamata, Masanori Fukushima, Ryosuke Kuroda
Format: Article
Language:English
Published: Elsevier 2022-04-01
Series:Asia-Pacific Journal of Sports Medicine, Arthroscopy, Rehabilitation and Technology
Subjects:
Autologous chondrocyte implantation
Third-generation
Knee
Online Access:http://www.sciencedirect.com/science/article/pii/S2214687322000061

Internet

http://www.sciencedirect.com/science/article/pii/S2214687322000061

Similar Items